Synopsis
The Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our Warning Letter dated May 26, 2023. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter.
Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.
Read the full story at FDA: drugs ↗
